Skip to main content
Premium Trial:

Request an Annual Quote

Daniel Caserza, Gail Page, Matthew Hogan, Jean-Michel Cossery, Leonard Herzenberg, Leonore Herzenberg, Tom DiLenge


Ciphergen this week said that Daniel Caserza, the company's interim chief financial officer, will resign effective from the company on June 2. Gail Page, president and CEO, will take his place until Ciphergen hires a replacement, the company said.

Ciphergen also said it has retained Financial Leadership Group to help it prepare its financial statements until it hires a permanent CFO.

Casera took over from Matthew Hogan, who abruptly resigned in March. Caserza joined Ciphergen in 1999. He became a vice president in April 2005.

GE Healthcare this week said that chief marketing officer Jean-Michel Cossery is now also vice-president, while Michael Jones, a general manager at GE since 1998, is now vice-president of business development.

Cossery is former executive vice president of global marketing at Amersham Health. He has an MBA from the Rotterdam School of Management, a PharmD in pharmacology, PhD in nuclear chemistry and neurology, and an MSs in organic chemistry and pharmacy from the University of Paris.

Jones, before joining GE, spent 10 years on Wall Street in a variety of M&A, private equity, and investment banking roles.

Invitrogen has formed a Flow Cytometry Scientifc Advisory Board, the company said last week. Leonard Herzenberg will chair the board and Leonore Herzenberg will join the board as a member.

The two play in immunology, flow cytometry, and cell biology.

As a part of the collaboration, the Herzenbergs will establish a scientific advisory board for immunology and flow cytometry and design and endorse educational materials and courses to expand the usage of flow cytometry.

Tom DiLenge was named vice-president and general counsel of the Biotechnology Industry Organization, the group said last week.

DiLenge joined BIO in November 2005 as deputy general counsel and has served as acting general counsel since the end of February. Prior to joining BIO, DiLenge served as the chief counsel and policy director for the House Homeland Security Committee and a senior counsel for the House Energy and Commerce Committee.

DiLenge graduated summa cum laude from Fordham University in 1988 and graduated with honors from the University of Virginia School of Law in 1993.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.